Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
OMT-28 by OMEICOS Therapeutics for Mitochondrial Myopathy: Likelihood of Approval
OMT-28 is under clinical development by OMEICOS Therapeutics and currently in Phase II for Mitochondrial Myopathy. According to GlobalData, Phase...
Data Insights
OMT-28 by OMEICOS Therapeutics for Cardiomyopathy: Likelihood of Approval
OMT-28 is under clinical development by OMEICOS Therapeutics and currently in Phase II for Cardiomyopathy. According to GlobalData, Phase II...